Literature DB >> 15952054

Gene 33 inhibits apoptosis of breast cancer cells and increases poly(ADP-ribose) polymerase expression.

Jie Xu1, Adam B Keeton, Liyu Wu, John L Franklin, Xu Cao, Joseph L Messina.   

Abstract

The structure of the Gene 33 protein suggests that it plays a role in intracellular signaling and Gene 33 is induced by many mitogenic and stressful stimuli. Previously, we found that Gene 33 expression is significantly induced by retinoic acid (RA), insulin and synergistically by both in a liver-derived cell line. In the present study, we investigated the basal expression and regulation of Gene 33 in multiple human breast cancer cell lines. These cell lines expressed different levels of Gene 33 protein, but Gene 33 protein was not regulated by RA or insulin, either alone, or in combination. However, epidermal growth factor (EGF) induced Gene 33 expression in SK-BR-3 cells and this induction was inhibited by co-treatment with RA. There was a strong correlation between endogenous basal Gene 33 expression and doubling time. Exogenous expression of Gene 33 in MCF-7 cells did not affect cell cycle distribution, but inhibited apoptosis and specifically increased the level of Poly(ADP-ribose) Polymerase (PARP-1) protein. This suggests that Gene 33 promotes breast cancer cell growth by an anti-apoptotic rather than a mitogenic effect, possibly involving up-regulation of PARP-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952054     DOI: 10.1007/s10549-005-1040-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  Nuclear Gene 33/Mig6 regulates the DNA damage response through an ATM serine/threonine kinase-dependent mechanism.

Authors:  Cen Li; Soyoung Park; Xiaowen Zhang; Leonard M Eisenberg; Hong Zhao; Zbigniew Darzynkiewicz; Dazhong Xu
Journal:  J Biol Chem       Date:  2017-08-25       Impact factor: 5.157

2.  Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.

Authors:  Nili Jin; Sung-Nam Cho; M Gabriela Raso; Ignacio Wistuba; Yvonne Smith; Yanan Yang; Jonathan M Kurie; Rudolph Yen; Christopher M Evans; Thomas Ludwig; Jae-Wook Jeong; Francesco J DeMayo
Journal:  Development       Date:  2009-08-26       Impact factor: 6.868

3.  Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells.

Authors:  W Xu; S Zhu; Y Zhou; Y Jin; H Dai; X Wang
Journal:  Cancer Gene Ther       Date:  2015-10-09       Impact factor: 5.987

4.  Insulin regulation of growth hormone receptor gene expression: involvement of both the PI-3 kinase and MEK/ERK signaling pathways.

Authors:  William L Bennett; Adam B Keeton; Shaonin Ji; Jie Xu; Joseph L Messina
Journal:  Endocrine       Date:  2007-11-27       Impact factor: 3.633

5.  The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6.

Authors:  Michael K Wendt; Whitney K Williams; Pete E Pascuzzi; Nikolas G Balanis; Barbara J Schiemann; Cathleen R Carlin; William P Schiemann
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

6.  Accelerated and increased joint damage in young mice with global inactivation of mitogen-inducible gene 6 after ligament and meniscus injury.

Authors:  Danese M Joiner; Kennen D Less; Emily M Van Wieren; Yu-Wen Zhang; Daniel Hess; Bart O Williams
Journal:  Arthritis Res Ther       Date:  2014-03-27       Impact factor: 5.156

7.  MIG-6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple-negative breast cancer.

Authors:  Jiabei He; Chien-Feng Li; Hong-Jen Lee; Dong-Hui Shin; Yi-Jye Chern; Bruno Pereira De Carvalho; Chia-Hsin Chan
Journal:  EMBO Rep       Date:  2021-03-03       Impact factor: 9.071

Review 8.  Gene 33/Mig6/ERRFI1, an Adapter Protein with Complex Functions in Cell Biology and Human Diseases.

Authors:  Dazhong Xu; Cen Li
Journal:  Cells       Date:  2021-06-22       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.